Skip to search formSkip to main contentSkip to account menu

budipine

Known as: 1-(1,1-Dimethylethyl)-4,4-diphenylpiperidine, piperidine, 1-(1,1-dimethylethyl)-4,4-diphenyl- 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Antiparkinson AgentsPiperidines

Narrower (1)

budipine hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen.
BACKGROUND The complex pharmacological profile of the antiparkinsonian drug budipine influences neurotransmission beyond the… 
2000
2000
Opposite effects of glutamate antagonists and antiparkinsonian drugs on the activities of DOPA decarboxylase and 5-HTP decarboxylase in the rat brain
Highly Cited
1999
Highly Cited
1999
Dual effects of l-3,4-dihydroxyphenylalanine on aromatic l-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine…
Review
1999
Review
1999
Clinical efficacy of budipine in Parkinson's disease.
The lipophilic t-butyl analog of 1-alkyl-4,4-diphenyl piperidine, budipine, possesses a polyvalent spectrum of mechanisms of… 
1999
1999
Tremorlytic activity of budipine in Parkinson's disease.
In order to objectively quantify the tremorlytic activity of budipine in Parkinson's disease (PD) we performed longterm tremor… 
1995
1995
Tremorlytic activity of budipine: a quantitative study with long-term tremor recordings.
The tremorlytic activity of the novel antiparkinson agent budipine was quantified in an open trial. Eleven patients with… 
1995
1995
The antiparkinsonian drug budipine binds to NMDA and sigma receptors in postmortem human brain tissue.
We have estimated the affinity of the antiparkinsonian drug budipine to the PCP binding site of the NMDA receptor and to sigma 1… 
1985
1985
The protective effect of 1-tert.butyl-4,4-diphenylpiperidine against the nigrostriatal neurodegeneration caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
1985
1985
Clinical Experiences with Budipine in Parkinson Therapy
Inevitably, reading is one of the requirements to be undergone. To improve the performance and quality, someone needs to have… 
1982
1982
[Summarizing description of the pharmacology of budipine, a new 4,4-diphenylpiperidine derivative used in Parkinson therapy (author's transl)].
Budipine is a new 1-tertiary-butyl-diphenylpiperidine derivative with primarily central action. In animal experiments involving… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)